Health Canada Issues Recall for Glucose Monitors Amid Health Risks

Health Canada has issued a recall for certain glucose monitors associated with serious health risks to diabetes patients. The federal agency is advising users to check their devices to determine if they are among the affected models, specifically the FreeStyle Libre 3 Plus sensors, which may provide inaccurate glucose readings.

These sensors are designed to measure glucose levels in interstitial fluid just beneath the skin, transmitting data wirelessly to a compatible device or smartphone. The recall stems from reports that incorrect readings could lead patients to mistakenly believe their glucose levels are low. This may result in excessive carbohydrate consumption or delays in insulin administration, both of which pose significant health risks.

According to a news release from Abbott Diabetes Care, the manufacturer of the devices, the affected products are potentially linked to seven deaths and over 700 injuries globally. An Abbott spokesperson confirmed that the company has not disclosed the countries where these incidents occurred, highlighting the severity of the situation.

While the FreeStyle Libre 3 model has also faced recalls in other countries, including the United States, Abbott clarified that it is not recalled in Canada. The company stated that it has identified and addressed the underlying production line issue that led to the discrepancies in readings.

Health Canada is urging users of the affected sensors to cease their use immediately, dispose of them, and request replacements. The model and serial numbers of the recalled products are available on Health Canada’s recall website, which can be accessed at https://recalls-rappels.canada.ca/en/alert-recall/freestyle-librer-3-plus-sensor-kit.

As of now, Health Canada has indicated that it will provide further responses but could not address specific inquiries by the deadline. The situation remains crucial for patients who rely on these devices for daily glucose monitoring.

This report is part of ongoing health coverage supported by a partnership with the Canadian Medical Association. The Canadian Press is solely responsible for this content, which was first published on December 5, 2025.